Neutrophil overactivity

Colchicine is a tricyclic alkaloid originally derived from the autumn crocus plant (Colchicum autumnale). It works primarily as an anti-inflammatory agent. Unlike most standard pain medications, it targets the cellular processes that drive inflammatory responses, making it highly effective for gout flares and other systemic autoinflammatory conditions. [1, 2, 3, 4]

Mechanism of Action (Pharmacodynamics)

Colchicine modulates the immune system by disrupting the structural scaffolding inside cells. [1]

• Inhibition of Microtubule Polymerization: The primary mechanism involves colchicine binding directly to tubulin, the protein building blocks of cellular microtubules. By blocking these tubules from assembling, colchicine effectively "freezes" the cell's internal transport system. [1, 2, 3, 4]
• Disruption of Neutrophil Function: White blood cells called neutrophils are the primary drivers of an acute gout attack. Without functioning microtubules, neutrophils lose their ability to change shape, migrate toward the affected joint (chemotaxis), or engulf uric acid crystals (phagocytosis). [1, 2, 3, 4]
• Suppression of the NLRP3 Inflammasome: Colchicine prevents the assembly of the NLRP3 inflammasome. This intracellular protein complex is responsible for activating interleukin-1β (IL-1β), a potent chemical messenger that triggers widespread pain and swelling. [1, 2, 3]

How the Body Processes It (Pharmacokinetics)

The way colchicine moves through the body dictates its narrow therapeutic index—meaning the gap between a therapeutic dose and a toxic dose is very small. [1, 2]

• Absorption: Colchicine is absorbed rapidly through the small intestine after oral intake, reaching peak concentrations in the bloodstream within 0.5 to 2 hours. Its average overall bioavailability is roughly 45% due to initial processing in the gut.
• Distribution: Colchicine distributes widely throughout tissues and has a particularly high affinity for white blood cells. While its half-life in the bloodstream is roughly 20 to 40 hours, it can remain active inside leukocytes for up to 60 hours, explaining its prolonged anti-inflammatory effects.
• Metabolism: The liver and intestinal walls heavily process the drug using the CYP3A4 enzyme pathway. Cellular clearing also relies heavily on P-glycoprotein (P-gp), an efflux pump that pushes the drug out of cells and into the gut or kidneys for removal.
• Excretion: The majority of colchicine (about 80%) is eliminated through bile and feces. The remaining 10% to 20% is cleared directly by the kidneys. [1, 2, 3, 4, 5, 6]

Clinical Relevance of Its Pharmacology

Understanding how colchicine is processed highlights why certain clinical precautions are necessary:

• The Danger of Interacting Substances: Any drug or substance that blocks the CYP3A4 enzyme or P-glycoprotein pump (such as grapefruit juice, clarithromycin, or certain heart medications) will cause colchicine levels to spike dangerously, increasing the risk of systemic toxicity. [1, 2]
• Organ Impairment: Because the liver breaks down the drug and the kidneys help excrete it, individuals with severe renal or hepatic impairment require significant dose reductions or must avoid colchicine entirely to prevent severe accumulation. [1, 2]